Back to Search
MICHAEL NOE, MD
MD
Geriatric Medicine (Internal Medicine) Physician
NPI: 1750345930Individual
Specialties, Licenses & Credentials
Geriatric Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Geriatric Medicine
Code: 207RG0300X
106190(NY)
Research & Publications (20)
Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150.
PMID 19136175·Radiother Oncol·2009
8-other
A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid.
PMID 19422829·J Immunol Methods·2009
4-observational
A short enantioselective synthesis of N-Boc-(2R,3R)-3-methyl-3-hydroxypipecolic acid from geraniol.
PMID 18338902·J Org Chem·2008
8-other
Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices.
PMID 17906935·Cancer Causes Control·2008
6-review
Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.
PMID 17935984·Bioorg Med Chem Lett·2007
4-observational
Discovery of novel isothiazole inhibitors of the TrkA kinase: structure-activity relationship, computer modeling, optimization, and identification of highly potent antagonists.
PMID 16632359·Bioorg Med Chem Lett·2006
8-other
3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: a cross-sectional quality-of-life survey.
PMID 16938814·Acta Oncol·2006
4-observational
Adenomyosis in endometriosis--prevalence and impact on fertility. Evidence from magnetic resonance imaging.
PMID 15919780·Hum Reprod·2005
8-other
Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.
PMID 15780611·Bioorg Med Chem Lett·2005
8-other
Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.
PMID 15911259·Bioorg Med Chem Lett·2005
8-other
Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.
PMID 15953722·Bioorg Med Chem Lett·2005
7-preclinical
Uterine peristaltic activity and the development of endometriosis.
PMID 15731324·Ann N Y Acad Sci·2004
6-review
3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.
PMID 15324896·Bioorg Med Chem Lett·2004
4-observational
[Pharmacogenomics in gynecology. Replies to the Zurich Discussion Panel].
PMID 12561784·Gynakol Geburtshilfliche Rundsch·2003
4-observational
Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.
PMID 14612527·Cancer Res·2003
7-preclinical
Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.
PMID 12951101·Bioorg Med Chem Lett·2003
7-preclinical
Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitors.
PMID 11992783·Bioorg Med Chem Lett·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3 GATES CIR
BUFFALO, NY 14209 - Phone
- (716) 887-4690
Quick Facts
- NPI
- 1750345930
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile